Attempts to evaluate the therapeutic potential of systemic delivery of rm-IL-21 to AML mice via adeno-associated viral vectors and to induce high levels of IL-21 failed due to IL-21-associated toxicities (data not shown). The gene discussed is IL21; the disease is acute myeloid leukemia.